Bisogno T et al. |
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. |
1998 |
Eur. J. Biochem. |
pmid:9688276
|
Van Der Stelt M and Di Marzo V |
Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. |
2004 |
Eur. J. Biochem. |
pmid:15128293
|
MacCarrone M et al. |
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. |
2001 |
Eur. J. Biochem. |
pmid:11168423
|
Fasia L et al. |
Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? |
2003 |
Eur. J. Biochem. |
pmid:12919314
|
Bisogno T et al. |
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. |
2001 |
Eur. J. Biochem. |
pmid:11277920
|
Salzet M et al. |
Comparative biology of the endocannabinoid system possible role in the immune response. |
2000 |
Eur. J. Biochem. |
pmid:10931174
|
Sugiura T et al. |
Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. |
1996 |
Eur. J. Biochem. |
pmid:8797835
|
Matias I et al. |
Presence and regulation of the endocannabinoid system in human dendritic cells. |
2002 |
Eur. J. Biochem. |
pmid:12153574
|
Kapoor S |
Modulation of intracellular pathways by anandamide and its evolving role in oncology. |
2013 |
Eur. J. Cancer |
pmid:23434147
|
Laezza C et al. |
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. |
2013 |
Eur. J. Cancer |
pmid:23434151
|
Rossi C et al. |
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. |
2008 |
Eur. J. Clin. Pharmacol. |
pmid:18004553
|
Di Marzo V et al. |
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. |
2009 |
Eur. J. Endocrinol. |
pmid:19745037
|
Adermark L et al. |
Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. |
2009 |
Eur. J. Neurosci. |
pmid:19120438
|
Millns PJ et al. |
Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors. |
2006 |
Eur. J. Neurosci. |
pmid:17229097
|
Sharkey KA et al. |
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. |
2007 |
Eur. J. Neurosci. |
pmid:17459108
|
Ryan D et al. |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. |
2007 |
Eur. J. Neurosci. |
pmid:17419758
|
Ahluwalia J et al. |
Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. |
2003 |
Eur. J. Neurosci. |
pmid:12823468
|
Sagan S et al. |
Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. |
1999 |
Eur. J. Neurosci. |
pmid:10051770
|
Cippitelli A et al. |
The anandamide transport inhibitor AM404 reduces ethanol self-administration. |
2007 |
Eur. J. Neurosci. |
pmid:17650118
|
Ali AB and Todorova M |
Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. |
2010 |
Eur. J. Neurosci. |
pmid:20345910
|
Lemak MS et al. |
Cannabinoid regulation in identified synapse of terrestrial snail. |
2007 |
Eur. J. Neurosci. |
pmid:18028114
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Rivera P et al. |
Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats. |
2013 |
Eur. J. Neurosci. |
pmid:23033907
|
Sousa-Valente J et al. |
Anandamide in primary sensory neurons: too much of a good thing? |
2014 |
Eur. J. Neurosci. |
pmid:24494681
|
Rea K et al. |
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. |
2014 |
Eur. J. Neurosci. |
pmid:24494683
|
Maccarrone M et al. |
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. |
2002 |
Eur. J. Neurosci. |
pmid:11982628
|
Holt S et al. |
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. |
2007 |
Eur. J. Pharmacol. |
pmid:17397826
|
Rodella LF et al. |
AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation. |
2005 |
Eur. J. Pharmacol. |
pmid:15680264
|
Wallace MJ et al. |
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. |
2002 |
Eur. J. Pharmacol. |
pmid:12359270
|
Kelley BG and Thayer SA |
Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15288572
|
Wagner JA et al. |
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11448486
|
Orliac ML et al. |
Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats. |
2007 |
Eur. J. Pharmacol. |
pmid:17482593
|
McQueen DS et al. |
Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats. |
2004 |
Eur. J. Pharmacol. |
pmid:15140635
|
Fowler CJ et al. |
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle. |
2004 |
Eur. J. Pharmacol. |
pmid:15145699
|
Bermúdez-Siva FJ et al. |
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16423347
|
Shimasue K et al. |
Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel. |
1996 |
Eur. J. Pharmacol. |
pmid:8904088
|
Walentiny DM et al. |
The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice. |
2011 |
Eur. J. Pharmacol. |
pmid:21300050
|
Lau AH and Chow SS |
Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells. |
2003 |
Eur. J. Pharmacol. |
pmid:12620517
|
Gifford AN et al. |
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). |
1999 |
Eur. J. Pharmacol. |
pmid:10556675
|
Zygmunt PM et al. |
The anandamide transport inhibitor AM404 activates vanilloid receptors. |
2000 |
Eur. J. Pharmacol. |
pmid:10822052
|
Zaniewska M et al. |
Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16730696
|
Randall MD et al. |
Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. |
1997 |
Eur. J. Pharmacol. |
pmid:9314035
|
Giuffrida A et al. |
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. |
2000 |
Eur. J. Pharmacol. |
pmid:11080522
|
Wise LE et al. |
Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. |
2007 |
Eur. J. Pharmacol. |
pmid:17217945
|
Calignano A et al. |
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. |
2001 |
Eur. J. Pharmacol. |
pmid:11426841
|
Lay L et al. |
Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. |
2000 |
Eur. J. Pharmacol. |
pmid:10720647
|
Sordelli MS et al. |
Cyclooxygenase-2 prostaglandins mediate anandamide-inhibitory action on nitric oxide synthase activity in the receptive rat uterus. |
2012 |
Eur. J. Pharmacol. |
pmid:22554772
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
Costa B et al. |
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. |
2002 |
Eur. J. Pharmacol. |
pmid:12163107
|
de Lago E et al. |
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:12163112
|